↓ Skip to main content

Aspiration therapy for obesity; a safe and effective treatment

Overview of attention for article published in BMC Obesity, December 2016
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#11 of 187)
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
9 news outlets
twitter
9 X users
facebook
1 Facebook page
googleplus
1 Google+ user

Citations

dimensions_citation
32 Dimensions

Readers on

mendeley
41 Mendeley
Title
Aspiration therapy for obesity; a safe and effective treatment
Published in
BMC Obesity, December 2016
DOI 10.1186/s40608-016-0134-0
Pubmed ID
Authors

Erik Norén, Henrik Forssell

Abstract

This study evaluated the efficacy and safety of the novel AspireAssist® Aspiration Therapy System for treatment of obesity, and its effect on patient's quality of life. A prospective observational study with 25 obese subjects, mean age 48 years (range 33-65), was performed. A custom gastrostomy tube (A-tube, Aspire Bariatrics) was percutaneously inserted during a gastroscopy performed under conscious sedation. Drainage and irrigation of the stomach were performed 3 times daily, 20 min after each meal, for 1-2 years. Efficient aspiration required thorough chewing of ingested food. Treatment included a cognitive behavioral weight loss program. Mean body mass index (BMI) at inclusion was 39.8 kg/m(2) (range 35-49). After 1 year mean (SD) BMI was 32.1 kg/m(2) (5.4), p < 0.01, and excess weight loss was 54.4% (28.8), p < 0.01. Quality of life, as measured with EQ-5D, improved from 0.73 (0.27) to 0.88 (0.13), p < 0.01. After 2 years BMI was 31.0 kg/m(2) (5.1), p < 0.01, and excess weight loss was 61.5% (28.5), p < 0.01. There were no serious adverse events or electrolyte disorders. Compliance was 80% after 1 year and 60% after 2 years. Aspiration therapy is an efficient and safe treatment for obesity, and weight reduction improves quality of life. Excess weight was approximately halved in a year, with weight stability if treatment was continued. Trial Register ISRCTN 49958132. Retrospectively registered 28/02/2014.

X Demographics

X Demographics

The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 41 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 41 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 5 12%
Student > Doctoral Student 5 12%
Researcher 4 10%
Student > Ph. D. Student 3 7%
Student > Postgraduate 2 5%
Other 5 12%
Unknown 17 41%
Readers by discipline Count As %
Medicine and Dentistry 12 29%
Biochemistry, Genetics and Molecular Biology 3 7%
Nursing and Health Professions 3 7%
Agricultural and Biological Sciences 2 5%
Psychology 1 2%
Other 1 2%
Unknown 19 46%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 70. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 April 2017.
All research outputs
#603,921
of 25,196,456 outputs
Outputs from BMC Obesity
#11
of 187 outputs
Outputs of similar age
#12,924
of 433,261 outputs
Outputs of similar age from BMC Obesity
#1
of 12 outputs
Altmetric has tracked 25,196,456 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 187 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.2. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 433,261 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 12 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.